New antibodies target “dark side” of influenza virus protein
New antibodies target “dark side” of influenza virus protein NIH researchers explore hidden, vulnerable region…
New antibodies target “dark side” of influenza virus protein NIH researchers explore hidden, vulnerable region…
CHICAGO, July 26, 2024 — The Alzheimer’s Association is disappointed by today’s decision by the…
The popular GLP-1 drugs Ozempic and Wegovy may reduce cravings for more than just food.…
Tools underestimate cardiovascular event risk in people with HIV NIH trial reveals need for more…